Latest News

Legend integration and NFL betting strength drove a beat on guidance.

Shift4 beat earnings soundly. Then the selling began.

Payments-based revenue rose 18% as Shift4 expanded across key verticals.

A CFO exit and cost cuts dominate, but B2B pipeline momentum stood out.

Novo Nordisk milestone payment shapes quarter as HCM readout nears.

Phase 3 LUCIDITY results keep avexitide on track toward a 2027 launch.

Federal deals and AI demand lifted results above guidance.

Oncology and AI-driven efficiencies anchor the quarter's stronger profit picture.

Record bookings and a fast-growing data center business shape an ambitious fiscal 2027 outlook.

Record revenue and earnings came with a sharp inventory build tied to AI demand.

Management flagged rising delinquencies ahead as recent book years season.

ClearanceJobs booked its best new business quarter ever as Dice renewals stayed under strain.

Record revenue and margins as AI and semiconductor demand surge across markets.

Spirent integration and data center demand drove a sharp revenue jump this quarter.

Tariff refunds lifted cash flow even as the revenue outlook turned flat.

Record flows and margin gains frame its pending First Eagle deal.

M&T Bank (NYSE:MTB) expects commercial real estate lending to grow in 2027 and sees opportunities to improve efficiency through automation, Chief Financial Officer Daryl Bible said during an investor event hosted by Fidelity Investments. Bible said the bank is entering 2027 optimistic, with two

DXP Enterprises (NASDAQ:DXPE) reported record third-quarter sales of $587.2 million, up 14.3% from a year earlier, as acquisitions and organic growth contributed to gains across all three business segments. Net income rose 24.2% to $26.9 million, or $1.64 per diluted share, from $21.6 million, or $

1-800 FLOWERS.COM (NASDAQ:FLWS) reported an 11.1% decline in fiscal first-quarter revenue, but executives said demand trends on its two primary websites improved as the gifting company prepared for the holiday season. Revenue from continuing operations fell to $171.4 million from $192.7 million a y

Chord Energy (NASDAQ:CHRD) reported approximately $442 million in adjusted free cash flow for the third quarter of 2026 and said it returned the majority to shareholders, as stronger base production and operating efficiencies supported a higher production outlook. On his first earnings call as chie

Cognition Therapeutics (NASDAQ:CGTX) is preparing a Phase III trial of its experimental drug zervimesine in dementia with Lewy bodies after reaching alignment with the U.S. Food and Drug Administration on a planned registrational study, executives said on the company’s third-quarter 2026 earnings ca

Cognex (NASDAQ:CGNX) reported record third-quarter revenue and raised its full-year 2026 outlook, citing broad-based demand, stronger logistics growth and cost controls. The machine vision company also said it expects its acquisition of RealSense to close in the fourth quarter. Revenue rose 19% yea

Carlyle Group (NASDAQ:CG) reported third-quarter distributable earnings of $433 million, or $1.12 per share, as a rise in realized performance revenue helped lift earnings per share 17% from a year earlier. The alternative asset manager expects fundraising to accelerate over the coming years, with

Cronos Group (NASDAQ:CRON) reported record third-quarter revenue, gross profit and adjusted EBITDA as cannabis sales grew in Israel, Canada and Germany, while executives outlined plans to expand in Europe following the company’s acquisition of Dutch cannabis producer CanAdelaar. Consolidated net re

Certara (NASDAQ:CERT) reported 4% revenue growth in the third quarter of 2026 as double-digit software growth offset a decline in services, while cost reductions and a favorable sales mix helped lift profitability. Revenue from continuing operations rose to $94.9 million for the quarter ended Sept.